An early-stage company should be valued using a documented range supported by more than one perspective: market evidence from genuinely comparable transactions, the economics and risk of future cash flows, and where relevant the cost or difficulty of recreating key assets. The negotiated financing price must then be assessed alongside dilution, investor rights and the capital required to reach the next milestone.
Key conclusions
- Define the purpose, valuation date and basis of value before choosing a method.
- Treat comparable transactions as evidence to adjust, not a multiple to copy.
- Cross-check market evidence against company-specific economics, assets and milestone risk.
- Evaluate the financing terms and post-money ownership alongside the headline pre-money valuation.
Why early-stage valuation resists a single formula
Early-stage companies often have limited revenue, negative cash flow and assets whose value depends on future commercialisation. Conventional earnings multiples may be unusable, while a discounted cash-flow model can appear precise even though its terminal value and discount rate dominate the answer.
The ATO’s market-valuation guide, written for tax purposes rather than capital raising, provides a useful discipline: the market, income and cost approaches are distinct recognised approaches; the method should suit the available evidence; assumptions should be transparent; and a secondary cross-check should be used where possible. A fundraising valuation has a different purpose, but the evidential discipline still applies.
Sentinel’s view is that the output should normally be a reasoned range, not a point estimate presented as fact.
Start with the valuation question
Record the valuation date, the securities being valued, the transaction purpose and whether the discussion concerns enterprise value, equity value, pre-money value or post-money value. These terms are not interchangeable.
Investor ownership ≈ new capital ÷ post-money value
If a company agrees a A$9 million pre-money valuation and raises A$3 million, the simple post-money value is A$12 million and the new investor owns 25% before considering option-pool changes, different share rights or transaction-specific adjustments.
Use three valuation perspectives
Market approach
Comparable transactions and listed companies can show how the market has priced businesses with similar characteristics. The work is in the adjustment. Compare business model, stage, revenue quality, growth, margins, capital intensity, geography, transaction date and security rights. A software company with recurring revenue is not automatically comparable to a technology company that must finance production assets.
Income approach
An income approach tests what future cash flows might support. For an early-stage business, scenario-weighted outcomes can be more informative than a single DCF. The model should make technical, commercial and financing risk visible rather than burying every uncertainty inside one discount rate.
Cost approach
Development cost does not automatically equal market value. However, replacement cost and the time required to recreate data, intellectual property, approvals, a specialised team or a tested process can provide a lower-bound or reasonableness check where those assets are transferable and useful to a market participant.
Illustrative valuation reconciliation
| Evidence | Indicated range | Principal limitation |
|---|---|---|
| Adjusted seed transactions | A$8m–A$12m | Terms and performance data are incomplete |
| Scenario-weighted income approach | A$7m–A$11m | Highly sensitive to adoption and funding assumptions |
| Replacement-cost cross-check | A$5m–A$7m | Does not capture all future commercial potential |
A conclusion of A$8 million to A$10 million might be supportable if the strongest evidence sits in that overlap. The selected fundraising price may still move because of investor demand, strategic value, the amount raised and the rights attached to the security. The example illustrates reconciliation; it is not a valuation opinion or market benchmark.
Common mistakes
- Selecting comparables because their multiples support the desired answer.
- Using announced transaction value without understanding preference rights or secondary sales.
- Applying a revenue multiple to forecast revenue as though execution risk has disappeared.
- Confusing enterprise value with equity value or pre-money with post-money value.
- Treating sunk development expenditure as proof of market value.
- Ignoring the option-pool increase, liquidation preference or control terms negotiated with the valuation.
Management checklist
- Define purpose, date, basis and the security being valued.
- Document each comparable and adjustment.
- Cross-check with an income or cost perspective where possible.
- Reconcile enterprise, equity, pre-money and post-money values.
- Model dilution and security rights, not only the headline price.
- State uncertainty, unavailable information and the range conclusion.
Related questions
Can a pre-revenue startup be valued?
Yes, but the range will rely more heavily on milestone evidence, market transactions, replacement considerations and scenario outcomes. The uncertainty should be explicit.
What is the best startup valuation method?
There is no universal best method. Use the approach most consistent with the available evidence and valuation purpose, then apply a credible cross-check.
Are revenue multiples reliable?
They can be useful when revenue quality, growth, margin, capital intensity, stage and transaction terms are genuinely comparable. A multiple without those adjustments is weak evidence.
Does the last funding round determine current value?
It is relevant evidence, but conditions, performance, elapsed time, security rights and the purpose of the new valuation may have changed.
Sources and scope
- Market valuation for tax purposes — Australian Taxation Office (reviewed 23 August 2026).
- Choose your funding — business.gov.au (reviewed 23 August 2026).
Sources support the general principles identified above. The analysis, framework and illustrative examples are Sentinel Capital’s professional judgement.
General information only. This article does not take account of any organisation’s circumstances and is not legal, tax, investment or financial-product advice. Obtain advice from appropriately qualified advisers before acting on a financing, valuation or governance matter.